Navigation Links
Beyond the DNA: Chemical signatures reveal genetic switches in the genome

Investigators from the Ludwig Institute for Cancer Research (LICR) and the University of California, San Diego (UCSD) School of Medicine have made a breakthrough in identifying functional elements in the human genome, according to a report published online today in Nature Genetics.

While the DNA sequence can identify genes (the 'what') within the genome, it cannot answer the more fundamental questions of 'how,' 'when' and 'where' gene products are expressed. However, the LICR team and collaborators have developed a novel method to identify and predict the 'promoter' and 'enhancer' regions that switch on transcription, the first step in gene expression. This study is an important step towards large-scale functional annotation of 'enhancers,' which establish the rate at which gene expression occurs and determine the tissues in which genes are expressed.

"The human genome is packaged within each cell by chromatin, a structure composed of DNA wrapped around proteins called histones," explains lead author Nathaniel Heintzman, from LICR and the UCSD Biomedical Sciences Graduate Program. "We used genome-scale approaches to analyze the chromatin architecture in human cells and discovered distinct signatures of modified histones that correspond to known promoters and enhancers. These findings enabled us to generate computational algorithms that identified hundreds of novel genomic regions with regulatory potential." Moreover, says Heintzman, this 'histone code' was able to accurately distinguish between promoters, from which gene transcription is directly initiated, and enhancer regions - some of which are very distant from the target gene - to which transcription-activating cofactors bind.

According to LICR's Dr. Bing Ren, the study's senior author and assistant professor at UCSD's Department of Cellular and Molecular Medicine, the method is widely applicable and its unbiased approach is likely to yield new information on gene expression and how
'"/>

Source:Ludwig Institute for Cancer Research


Page: 1 2

Related biology news :

1. Beyond lithium for bipolar disorder
2. Beyond genes: Lipid helps cell wall protein fold into proper shape
3. Beyond the book: Software automates access to brain atlases
4. Chemicals in tattoo inks need closer scrutiny
5. Roots Engage in Underground Chemical Warfare
6. Chemical Engineer Kao Explores Antibiotic Synthesis With DNA Chips
7. Chemical band-aid prevents heart failure in mice with muscular dystrophy
8. Chemical compound inhibits tumor growth, size in new mouse study
9. T-rays: New imaging technology spotlighted by American Chemical Society
10. Chemical warfare agent detection technology used to treat lung disease
11. Chemical guidance of T cells leads to immunologic memory and long-term immunity

Post Your Comments:
(Date:11/4/2009)...,, CARLSBAD, Calif., Oct. 23 Ge...ure biosample management for genomic discovery, me...vid Wellis, Ph.D., GenVault,s President and CEO, w...e taking place on October 26th and 27th in La Joll...ill provide an overview of the company together wi...
(Date:11/4/2009)...,, NEW YORK, Oct. 27 Global Rai...mpany and advanced R&D laboratory, today annou...e and is prepared to actively commercialize its su...dge biometric security offerings. ,, During the...llions of dollars to develop and deploy a series o...
(Date:11/4/2009)...,, CARLSBAD, Calif., Nov. 4 Gen...hat William Brody, M.D., Ph.D., has joined its Boa...idential Chair of the Salk Institute, is an acclai...ior to joining the Salk Institute, Dr. Brody serve...e is a member of the National Academy of Engineeri...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Secretary Shinseki Moves to Simplify PTSD Compensation Rules 55136 1Secretary Shinseki Moves to Simplify PTSD Compensation Rules 55136 2Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 1Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 2Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 3Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 4IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 1IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 2
...mall molecules containing platinum, Virginia Commo...s have created a process to inhibit a class of pro...may help researchers develop new drugs to fight HI...n as zinc fingers. , In the May 30 issue of the j...ed that a zinc finger protein, known as HIV NCp7, ...
...earcher Zafira CastaƱo has discovered that the los...favors tumor growth. This was the conclusion that ...tion which she defended at the University of Navar...h prior studies from her laboratory, which demonst...cells that coat the normal lung, and which, nevert...
...ty crayfish - a voracious, bullying exotic that ha...akes - may have finally met its match. , Since it... 1950s, the crayfish has spread to thousands of la...sts that are critical fish habitat, evicting the n...r and scooping up fish eggs like so much caviar. ...
Other Biology News:New protein target may advance design of HIV and cancer drugs 2Study shows hope for ridding lakes of clawed invader 2Study shows hope for ridding lakes of clawed invader 3
(Date:11/6/2009)...A, Ontario, Nov. 6 Helix...XBPF) today announced that John Docherty, presiden...riman Curhan Ford,s 6th annual Investor Summit on ...in New York City. Mr. Docherty will provide an ov...t programs L-DOS47 and Topical Interferon Alpha-2b...
(Date:11/6/2009)...G VALLEY, Calif., Nov. 6 Calbiotec... Small Business Innovative Research (SBIR) Phase I...terial command. Under terms of the agreement, Calb...s) for the diagnosis of Dengue virus. ,, Den...sents a major threat to military forces deployed t...
(Date:11/5/2009)...ORTATION -- Gone hybrid . . . , Fuel economy r... now posted at the www.fueleconomy.gov web site,... maintains for the U.S. Department of Energy and t...he top 10 vehicles on the best fuel economy list a...PG city; 48 highway). "This list proves that hybri...
(Date:11/5/2009)...IEGO, Nov. 5 Imagenetix,...that William Spencer, President and CEO of Imagene... 2nd annual LD MICRO Conference on Thursday, Decem... Angeles. ,, About LD MICRO ,, LD MICRO is a...n finding undervalued companies in the micro-cap s...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...s., Oct. 31 Idenix,Pharmaceuticals, Inc., (Nasdaq...financial results for the third quarter of 2007 on... markets close. In conjunction with the issuance ...a conference call at 4:30 p.m. ET on Tuesday, Nove...sults for the third quarter,2007. To access the c...
...ct. 31 Modigene Inc. (OTC,Bulletin Board: MODG) t...,at the Acumen BioFin Rodman & Renshaw 9th Annual ...07 at 1:40 pm ET. The conference will be held at,t...ne CEO Abraham Havron and President Shai Novik wil...ew and review of corporate,developments. The pres...
.... 31 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS )...n,BioFin(TM) Rodman & Renshaw 9th Annual Healthcar...p.m. EST (1:25 p.m. PST). The conference is being,... Ph.D., President and Chief Executive Officer of A...ew of Anadys and its two,development-stage product...
Other Biology Technology:Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference 2
MHC Volume 1 from Promega
Propidium Iodide (1 mg/ml). from BioVision
Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG
Goat Anti-Qa-1 (L-12) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: